ENTRY       D10587            Mixture   Drug
NAME        Canagliflozin and metformin;
            Invokamet (TN)
PRODUCT     CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (Janssen Pharmaceuticals)
COMPONENT   (Metformin hydrochloride [DR:D00944] | Metformin [DR:D04966]), Canagliflozin hydrate [DR:D09592]
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG03034  Combination of metformin and SGLT2 inhibitor
REMARK      ATC code: A10BD16
            Product: D10587<US>
EFFICACY    Antidiabetic
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BD Combinations of oral blood glucose lowering drugs
                 A10BD16 Metformin and canagliflozin
                  D10587  Canagliflozin and metformin &lt;US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Combinations
               Canagliflozin/ Metformin Hydrochloride
                D10587  Canagliflozin and metformin
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG03034  Combination of metformin and SGLT2 inhibitor
                D10587  Canagliflozin and metformin
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               D10587  Canagliflozin and metformin
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10587
DBLINKS     PubChem: 254741549
///
